Noninvasively measuring respiratory activity of rat primary hepatocyte spheroids by scanning electrochemical microscopy

详细信息    查看全文

• 作者：Ryosuke Takahashi ; Yuanshu Zhou ; Yoshiko Horiguchi ; Hitoshi Shiku ; Hiroshi Sonoda ; Naoshi Itabashi ; Jiro Yamamoto ; Taku Saito ; Tomokazu Matsue ; Akiko Hisada
• 关键词：Spheroid ; Nanopillar sheet ; Scanning electrochemical microscopy ; Real-time PCR
• 刊名：Journal of Bioscience and Bioengineering
• 出版年：January, 2014
• 年：2014
• 卷：117
• 期：1
• 页码：113-121
• 全文大小：1456 K

文摘

Construction of an in vitro drug screening method for evaluating drug metabolism and toxicity by using cells is required instead of the conventional in vivo one that uses animals. In order to realize the in vitro study, analyzing the cellular activity or viability noninvasively in advance of the screening is essential. The aim of the current study is to establish a method that can evaluate the cellular activity depending on spheroid sizes by means of oxygen consumption and to determine the valid diameter of hepatocyte spheroids. To measure the respiratory activity of the spheroids, which were formed on a nanopillar sheet, we applied scanning electrochemical microscopy (SECM). From the viewpoint of high respiratory activity and its small variation, we determined that spheroids with 70聽渭m in diameter were adequate. We then performed a gene expression analysis by using a real-time PCR to evaluate the correlation with respiratory activity. As a result, a higher expression level of Hnf4伪, which is essential for hepatocytes to fulfill many liver functions and is the indicator of well-differentiated hepatocytes, showed relatively higher respiratory activity. We concluded that the noninvasive SECM technique could evaluate the cellular activity of a single spheroid. Noninvasively measuring cellular activity by SECM makes it possible to evaluate the cellular activity prior to a nonclinical test and enables the continued monitoring of the drug response by using single spheroid. SECM becomes a powerful tool to satisfying the increasing demand for an in vitro system in the course of new drug development.